Two studies suggest limited antigen‐specific IgE titer change in pollen allergic individuals over a four‐month period with dupilumab alone, which would instead indicate persistent IgE+ ASC cause pollen allergy.179, 180. The gene discussed is IGHE; the disease is seasonal allergic rhinitis.